• FDA Approves KEYTRUDA
    Categories: ,

    FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients with Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)

    30 Jan 2023

  • Logos of EORTC and Alliance for Clinical Trials in Oncology and man with mustaches to represent Movember.
    Categories: ,

    Completion of Patient Recruitment for International TIGER Study

    19 Dec 2022

  • Fingers holding a shamrock, the symbol of Ireland, in the sky.
    Categories: , , , , ,

    EORTC, CTI, and IRROG collaboration opens new opportunities in Ireland

    12 Dec 2022

  • EORTC, SPO and AICIB establish a partnership to promote cancer clinical research in Portugal
    Categories:

    EORTC, SPO and AICIB establish a partnership to promote cancer clinical research in Portugal

    2 Dec 2022

  • Stakeholders’ consensus response to the proposed European Health Data Space
    Categories:

    Stakeholders’ consensus response to the proposed European Health Data Space

    29 Nov 2022

  • Content validity of EORTC QLQ-C30 questionnaire
    Categories: ,

    Concepts assessed in the EORTC QLQ-C30 questionnaire are important and relevant for patients with cancer

    25 Nov 2022

  • Validation of QLQ-ANL27 anal-cancer specific questionnaire
    Categories: , ,

    First EORTC anal cancer-specific questionnaire validated

    18 Nov 2022

  • HRH Princess Dina Mired_Dr Amal AlOmari_Dr Mansour_Dr Abdel-Razeq_Dr Lacombe_Count du Monceau_EORTC_KHCC signing event
    Categories:

    EORTC and KHCC sign first Middle Eastern collaboration agreement

    17 Nov 2022